EUVIMEDScopri EUVIMED
Open access

Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells

Catherine E Oliver iD, Hailee Patel, James Hong iD, Jonathan Carter, William E Kraus, Kim M Huffman, George A Truskey

Journal of Tissue Engineering and Regenerative Medicine · 2022-02 · 16 (2) · 128-139

DOI: 10.1002/term.3266 ↗

At a glance

Journal article in Journal of Tissue Engineering and Regenerative Medicine, published online on 2021-11-20. Written by Catherine E Oliver and 6 co-authors. Institution: Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA. Major MEDLINE topics: Arthritis, Rheumatoid, Muscle, Skeletal. Cited 16 times so far (Crossref); 38 references. The full text is freely available in PubMed Central. Funded by: NIAMS NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Rheumatoid arthritis (RA) is a chronic inflammatory disease primarily targeting the joints. Autoreactive immune cells involved in RA affect other tissues, including skeletal muscle. Patients with RA experience diminished physical function, limited mobility, reduced muscle function, chronic pain, and increased mortality. To explore the impact of RA on skeletal muscle, we engineered electrically responsive, contractile human skeletal muscle constructs (myobundles) using primary skeletal muscle cells isolated from the vastus lateralis muscle of 11 RA patients (aged 57-74) and 10 aged healthy donors (aged 55-76), as well as from the hamstring muscle of six young healthy donors (less than 18 years of age) as a benchmark. Since all patients were receiving treatment for the disease, RA disease activity was mild. In 2D culture, RA myoblast purity, growth rate, and senescence were not statistically different than aged controls; however, RA myoblast purity showed greater variance compared to controls. Surprisingly, in 3D culture, contractile force production by RA myobundles was greater compared to aged controls. In support of this finding, assessment of RA myofiber maturation showed increased area of sarcomeric α-actinin (SAA) expression over time compared to aged controls. Furthermore, a linear regression test indicated a positive correlation between SAA protein levels and tetanus force production in RA and controls. Our findings suggest that medications prescribed to RA patients may maintain-or even enhance-muscle function, and this effect is retained and observed in in vitro culture. Future studies regarding the effects of RA therapeutics on RA skeletal muscle, in vivo and in vitro, are warranted.

Subjects

MeSH terms (MEDLINE)

Arthritis, RheumatoidMuscle, SkeletalAgedHumansMiddle AgedMuscle ContractionMuscle Fibers, SkeletalMyoblasts

Author keywords

human skeletal muscleinflammationrheumatoid arthritistissue engineering

Authors and institutions

  • Department of Biomedical Engineering, Duke University, Durham, North Carolina, USA.
  • Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID profiles: Catherine E Oliver, James Hong

Funding

  • NIAMS NIH HHS
  • NCATS NIH HHS
  • NIH HHS

Cite

APA

Oliver, C. E., Patel, H., Hong, J., Carter, J., Kraus, W. E., Huffman, K. M., & Truskey, G. A. (2022). Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells. Journal of Tissue Engineering and Regenerative Medicine, 16(2), 128-139. https://doi.org/10.1002/term.3266

Vancouver

Oliver CE, Patel H, Hong J, Carter J, Kraus WE, Huffman KM, et al. Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells. Journal of Tissue Engineering and Regenerative Medicine. 2022;16(2):128-139. doi:10.1002/term.3266

BibTeX
@article{Oliver2022,
  author = {Oliver, Catherine E and Patel, Hailee and Hong, James and Carter, Jonathan and Kraus, William E and Huffman, Kim M and Truskey, George A},
  title = {Tissue engineered skeletal muscle model of rheumatoid arthritis using human primary skeletal muscle cells},
  journal = {Journal of Tissue Engineering and Regenerative Medicine},
  year = {2022},
  volume = {16},
  number = {2},
  pages = {128--139},
  doi = {10.1002/term.3266}
}
Start for free →